The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
|Articles|July 2, 2018
- Pharmaceutical Technology-07-02-2018
- Volume 42
- Issue 7
High-Shear Mixer with Additional Disperser
The PowerMix Model PDM-10 from Ross, Charles & Son offers high-shear mixing for hard-to-mix applications with low flowability.
The PowerMix Model PDM-10 from Ross, Charles & Son offers high-shear mixing for hard-to-mix applications with low flowability. The mixer combines high-speed dispersion with planetary stirring action making it suitable for heavy pastes and slurry-like applications involving a considerable amount of powders that need to be wetted out and dispersed uniformly.
The 10-gallon model features interchangeable mix vessels and an additional sawtooth blade on each disperser shaft, which doubles the shear input capacity of the mixer, according to the company. A rectangular stirrer orbits the vessel, exposing the entire batch contents to the shearing action of the dispersers.
Patented high viscosity blades are available for more viscous applications prone to climbing up the stirrer. The blades offer a helical curvature that pushes product forward and downward. Fully automated programmable logic controller recipe controls and data acquisition systems are also available for optimal mixing results, as stated by the company.
Articles in this issue
over 8 years ago
Selecting Primary Packaging for Parenteralsover 8 years ago
Testing Foreign Particulate Matter in Inhaled Productsover 8 years ago
Data Loggers with Cloud Storageover 8 years ago
Particle Sizer for Dry and Wet Measurementover 8 years ago
Benchtop Bioreactor for Mammalian and Microbial Modelsover 8 years ago
Be Quick, But Don’t Hurryover 8 years ago
The Search for Next-Gen Expression Systemsover 8 years ago
Selecting Excipients for Controlled ReleaseRelated to this article
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.